In summary, over the last ten years essentially the most extraordinary benefit is realized in HER2/neu-overexpressing MBC. Introduction of bevacizumab being a VEGF-directed specific procedure stays a concern on debate. A few of the novel therapeutics towards the breast cancer armamentarium resulted in prolongation of survival for sufferers with MBC… Read More